NuvOx Pharma LLC - Company Review
NuvOx Pharma LLC - Company ReviewSummary
NuvOx Pharma LLC (NuvOx Pharma) focuses on the development of oxygen therapeutics for the treatment of human conditions. It utilizes the dodecafluoropentane (DDFP) platform to develop novel therapies. NuvOx Pharma’s pipeline portfolio includes compounds such as NVX-108 to treat the indication of cancer; NVX-208, to treat stroke, NVX-308, treat heart attack, NVX-428, to treat and NVX-408 to treat the Hemorrhagic Shock. It also conducts research and develops drugs for other diseases such as ultrasound, eye disease and wound healing. The company develops therapies in partnership with the other organizations such as NIH and US Navy. NuvOx Pharma is headquartered in Tucson, Arizona, the US.
This comprehensive company report of NuvOx Pharma LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.